Literature DB >> 10682686

Evidence of a founder BRCA1 mutation in Scotland.

A Liede1, B Cohen, D M Black, R H Davidson, A Renwick, E Hoodfar, O I Olopade, M Micek, V Anderson, R De Mey, A Fordyce, E Warner, J L Dann, M C King, B Weber, S A Narod, C M Steel.   

Abstract

BRCA1 mutations have been identified in breast and ovarian cancer families from diverse ethnic backgrounds. We studied 17 different families with the BRCA1 2800delAA mutation; seven were ascertained in Scotland (Dundee, Edinburgh, Glasgow, St Andrews), five in Canada (Toronto, Victoria) and five in the United States (Chicago, Philadelphia, Seattle). Overall there was a clear preponderance of Scottish ancestry. Genotype analysis performed on key members from 17 families was consistent with a common haplotype, strongly suggesting a single ancestral origin. A possible link was established between two families by tracing their genealogies through the records of the Registrar General for Scotland. This is the first example of a BRCA1 mutation likely to be derived from a common founder in Scotland. Further studies will be necessary to estimate more accurately the population frequency of the BRCA1 2800delAA mutation among unselected cases of breast and ovarian cancer in Scotland and the UK.

Entities:  

Mesh:

Year:  2000        PMID: 10682686      PMCID: PMC2363321          DOI: 10.1054/bjoc.1999.0984

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  30 in total

Review 1.  Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families.

Authors:  P Tonin; B Weber; K Offit; F Couch; T R Rebbeck; S Neuhausen; A K Godwin; M Daly; J Wagner-Costalos; D Berman; G Grana; E Fox; M F Kane; R D Kolodner; M Krainer; D A Haber; J P Struewing; E Warner; B Rosen; C Lerman; B Peshkin; L Norton; O Serova; W D Foulkes; J E Garber
Journal:  Nat Med       Date:  1996-11       Impact factor: 53.440

2.  A breast cancer patient of Scottish descent with germ-line mutations in BRCA1 and BRCA2.

Authors:  A Liede; P Rehal; D Vesprini; E Jack; J Abrahamson; S A Narod
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

3.  Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer.

Authors:  S J Ramus; Z Kote-Jarai; L S Friedman; M van der Looij; S A Gayther; B Csokay; B A Ponder; E Olah
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

4.  The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

Authors:  J P Struewing; P Hartge; S Wacholder; S M Baker; M Berlin; M McAdams; M M Timmerman; L C Brody; M A Tucker
Journal:  N Engl J Med       Date:  1997-05-15       Impact factor: 91.245

5.  Frequency of breast cancer attributable to BRCA1 in a population-based series of American women.

Authors:  B Newman; H Mu; L M Butler; R C Millikan; P G Moorman; M C King
Journal:  JAMA       Date:  1998-03-25       Impact factor: 56.272

6.  The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.

Authors:  J P Struewing; D Abeliovich; T Peretz; N Avishai; M M Kaback; F S Collins; L C Brody
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

7.  Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.

Authors:  S L Neuhausen; S Mazoyer; L Friedman; M Stratton; K Offit; A Caligo; G Tomlinson; L Cannon-Albright; T Bishop; D Kelsell; E Solomon; B Weber; F Couch; J Struewing; P Tonin; F Durocher; S Narod; M H Skolnick; G Lenoir; O Serova; B Ponder; D Stoppa-Lyonnet; D Easton; M C King; D E Goldgar
Journal:  Am J Hum Genet       Date:  1996-02       Impact factor: 11.025

8.  Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Authors:  D F Easton; D Ford; D T Bishop
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

9.  BRCA1 5382insC mutation in sporadic and familial breast and ovarian carcinoma in Scotland.

Authors:  P Mullen; W R Miller; J Mackay; D R Fitzpatrick; S P Langdon; J P Warner
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  BRCA1 and BRCA2 in breast cancer families from Wales: moderate mutation frequency and two recurrent mutations in BRCA1.

Authors:  J M Lancaster; M E Carney; J Gray; J Myring; C Gumbs; J Sampson; D Wheeler; E France; R Wiseman; P Harper; P A Futreal
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

View more
  6 in total

1.  Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families.

Authors:  Hélène Vézina; Francine Durocher; Martine Dumont; Louis Houde; Csilla Szabo; Martine Tranchant; Jocelyne Chiquette; Marie Plante; Rachel Laframboise; Jean Lépine; Heli Nevanlinna; Dominique Stoppa-Lyonnet; David Goldgar; Peter Bridge; Jacques Simard
Journal:  Hum Genet       Date:  2005-05-10       Impact factor: 4.132

2.  Cross-sectional clinical cancer genomics community of practice survey analysis of provider attitudes and beliefs regarding the use of deceased family member tissue to guide living family member genetic cancer risk assessment.

Authors:  Bita Nehoray; Thomas P Slavin; Can-Lan Sun; Karen Hurley; Elisabeth King; Kevin K Tsang; Aleck Cervantes; Janet V Mokhnatkin; Sharon Sand; Rosa Mejia; Anne Reb; Goli Samimi; Stacy Gray; Kathleen R Blazer; Jeffrey N Weitzel
Journal:  J Genet Couns       Date:  2022-05-26       Impact factor: 2.717

3.  BRCA1 and BRCA2 mutations in Scotland and Northern Ireland.

Authors: 
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

4.  Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer.

Authors:  Susan M Domchek; Jiangbo Tang; Jill Stopfer; Dana R Lilli; Nancy Hamel; Marc Tischkowitz; Alvaro N A Monteiro; Troy E Messick; Jacquelyn Powers; Alexandria Yonker; Fergus J Couch; David E Goldgar; H Rosemarie Davidson; Katherine L Nathanson; William D Foulkes; Roger A Greenberg
Journal:  Cancer Discov       Date:  2012-12-26       Impact factor: 39.397

Review 5.  A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.

Authors:  Fatemeh Karami; Parvin Mehdipour
Journal:  Biomed Res Int       Date:  2013-11-07       Impact factor: 3.411

6.  Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.

Authors:  Ramūnas Janavičius
Journal:  EPMA J       Date:  2010-06-27       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.